Browse Videos
Full Episodes
- Mary Fisher, SkinMedica
- Mary Fisher, CEO of SkinMedica, discusses the opportunity in selling to physicians directly, the future of dermatology.
- Gilbert Lam, MicroConstants
- MicroConstants President and CSO Gilbert Lam discusses the CRO's capabilities in pharmacokinetics, bioanalytics, formulation, and metabolism.
- Terrance J. Bruggeman, BioTork
- Terrance J. Bruggeman discusses BioTork's natural solution to the BP oil spill cleanup using variants of naturally occurring organisms.
- Ezra Ernst, Medscape
- Ezra Ernst discusses how to keep physicians current with the latest information and studies via professional development and CME services.
- Philip Ginsburg, Allied Path
- Philip Ginsburg discusses Allied Path's analysis process for genetic mutation in tumors to tailor treatment to the individual's cancer.
- Nikolay Savchuk, ChemDiv
- ChemDiv CEO Nikolay Savchuk discusses the growing and evolving role of his company and other CROs in the development of therapeutics from target to clinic to manufacturing.
- Terrance J. Bruggeman, BioTork
- Terrance J. Bruggeman discusses BioTork's natural solution to the BP oil spill cleanup using non-genetically modified microorganisms.
- David Sun, Nanogea
- David Sun discusses how nano-cone chemistry and enabled atomic force technology combine to form the most sensitive molecular diagnostic platform.
- Kim Lim, Ultimate Labs
- Kim Lim discusses Ultimate Lab’s contamination prevention capabilities, outsourcing services within San Diego, how CROs drive profit margin.
- Mark McWilliams, Medipacs
- Mark McWilliams discusses the potential of disposable infusion pumps including safety implications, cost savings.
- Richard Henson, Source Scientific
- Richard Henson on the growing complexity of medical instrumentation, the role of outsourcing product development for the next five years.
- Mary Fisher, SkinMedica
- Mary Fisher, CEO of SkinMedica, discusses the opportunity in selling to physicians directly, the future of dermatology.
- Mike Ferletic, Enterey Inc.
- Mike Ferletic discusses the benefits of a virtual business model, and offers a case study for building operational efficiency.
Quick Views
Short video clips on a variety of biotech industry topics from top biotech executives.
- Video Roll Ins
- Specific Video Page Banner Ads
- Homepage Banner Ads
- Sitewide Banner Ads
